Patent application number | Description | Published |
20080262007 | Hiv Inhibiting 5-Substituted Pyrimidines - HIV replication inhibitors of formula | 10-23-2008 |
20080287511 | Anthelmintic Imidazol-Thiazole Derivates - The present invention relates to the novel anthelmintic compound tetrahydro-furan-2-carboxylic acid-[3-(2,3,5,6-tetrahydro-imidazo[2,1-b]thiazol-6-yl)-phenyl]-amide and the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, as well as pharmaceutical compositions comprising said novel compound, processes for preparing said compound and compositions, and the use thereof as a medicine, in particular in treatment, control and prevention of endo- and ectoparasite infections in warm-blooded animals. | 11-20-2008 |
20090012092 | Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives - The present invention relates to HIV replication inhibitors of formula | 01-08-2009 |
20090124644 | HIV INHIBITING 2-(4-CYANOPHENYLAMINO) PYRIMIDINE DERIVATIVES - HIV replication inhibitors of formula | 05-14-2009 |
20090181993 | HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES - HIV replication inhibitors of formula (I), N-oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a | 07-16-2009 |
20110077261 | PREVENTION OF HIV-INFECTION - This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals. | 03-31-2011 |
20120076835 | HIV INHIBITING PYRIMIDINES DERIVATIVES - This invention concerns HIV replication inhibitors of formula | 03-29-2012 |
20120190697 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES - HIV replication inhibitors of formula | 07-26-2012 |